Clinical trial NCT01339715: The Difference Between Acupuncture and Far-infrared Ray Illumination at CV12 Acupoint
Official title: From the Changes of Ryodoraku Value at 12 Source Acupoints, and Heart Rate Viability to Explain the Difference Between Acupuncture and Far-infrared Ray Illumination at CV12（Zhongwan）Acupoint
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Reaction of Autonomic Nervous System
Reaction of Acupuncture
Reaction of Far Infrared Ray
Keywords: Ryodoraku
Heart Rate Variability
Traditional medicine
Autonomic Nervous System
Acupuncture
Far Infrared Ray
CV12 Acupoint
Lead sponsor: China Medical University Hospital
Sponsor class: OTHER
First posted: 2011-04-21
Enrollment: 25
Sex: ALL
Minimum age (years): 20
Maximum age (years): 40
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: BASIC_SCIENCE

Brief summary: The purpose of the study was to investigate the changes of Ryodoraku value at 12 source acupoints, and heart rate viability (HRV) when acupuncture or far-infrared ray illumination applied to CV12 acupoint.

Detailed description: Acupuncture and far-infrared ray illumination at CV12 acupoint have been widely used to treat many diseases in clinic. To our knowledge, the report is about the different reaction on autonomic nervous system between acupuncture and far-infrared illumination is very rare until now.Therefore,the study was to investigate the different changes on autonomic nervous system from Ryodoraku value at 12 source acupoints and heart rate viability (HRV) when acupuncture or far-infrared ray illumination applied to CV12 acupoint.

Eligibility criteria: Inclusion Criteria:

* Healthy adult volunteers, male or female, ages between 20 and 40
* Neurological and physical examination without abnormal functions
* Far-infrared ray illumination without allergic reaction and contra- indication
* The participants were explained the objective of the study, agreed to accept the test and signed a letter of consent

Exclusion Criteria:

* People less than 20 years of age or more than 40 years
* Women in pregnant or lactating
* People with mental or behavioral anomalies could not follow the researchers
* People with pacemakers
* People suffered from serious diseases such as myocardial infarction , heart failure, serious arrhythmia, hypertension, diabetes, autoimmune disease, chronic obstructive pulmonary diseases, and kidney failure, liver cirrhosis and cancer
* People accepted acupuncture and moxibustion in a week, or were taking any drugs for treatment
* People suffered from limb edema and serious skin diseases
* People with excessive obesity (body mass index, BMI\>30)
* People did not sign a letter of consent

Primary outcomes:
measure: From the changes of Ryodoraku value at 12 source acupoints, and heart rate viability to measure the difference
timeFrame: Each period was 20 min in duration. The Ryodoraku value of 12 source acupoints were measured, and 5-min HRV was recorded at the end of each period.
Secondary outcomes:
Other outcomes:
Locations:
city: Taichung
country: Taiwan
facility: China Medical University Hospital
Study officials:
affiliation: China Medical University Hospital
name: Ching-Liang Hsieh, professor
role: STUDY_CHAIR
References: